Nephrodite Inc.'s Holly, an implantable, continuous renal replacement system, received U.S. FDA breakthrough device designation as a novel and potentially life-changing treatment for end-stage kidney ...
Gene editing can repair mutations that prematurely halt protein synthesis, resulting in incomplete peptides that cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback